US 7396860
Use of rasagiline with or without riluzole to treat amyotrophic lateral sclerosis
granted A61KA61K31/135A61K31/428
Quick answer
US patent 7396860 (Use of rasagiline with or without riluzole to treat amyotrophic lateral sclerosis) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Jul 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue Jul 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/135, A61K31/428, A61P, A61P25/00